Symptom-based liver enzyme and triglyceride testing is proposed for isotretinoin patients without risk factors to reduce ...

FDA approved veligrotug-vvze for TED regardless of activity or duration, using a 12-week course of five IV infusions administered every three weeks. Pivotal THRIVE/THRIVE-2 trials met primary and all ...

CAA 2026 mandates rebate pass-through and at least twice-yearly reporting on spread pricing, acquisition costs, and rebate amounts. Enforcement provisions include $10,000-per-day penalties for ...

IQVIA projects 118 U.S. biologics losing exclusivity by 2034 (~$234B opportunity), but only 12 had biosimilars in development as of Sept 2024, leaving most molecules uncontested. FDA draft guidance ...

Identify the differences between a PBM and a PBA solution when it comes to a pharmacy benefit offering. Examine how testing benefit changes within a production environment help prevent claim ...

Improving outcomes in chronic conditions will require eliminating friction and creating a connected foundation that supports people continuously. For the millions of Americans living with a chronic ...

Centanafadine XR 280 mg QD significantly reduced AISRS total scores at week 8 versus placebo (LS mean change -18.5 vs -12.6; treatment difference -5.87). Improvement in comorbid anxiety was ...

TriNetX EHR analysis of 16,569 vitiligo patients versus matched controls demonstrated higher rates of depression, anxiety, panic disorder, insomnia, and nonorganic sexual dysfunction, with slightly ...

Zanubrutinib plus rituximab demonstrated a clinically meaningful progression-free survival advantage over bendamustine plus rituximab in previously untreated MCL, with a 43% risk reduction for ...

Broad formulary uptake includes unrestricted access via UnitedHealthcare, Express Scripts, Cigna, Optum Rx, and TRICARE, with prior authorization common among some Blue Cross plans and CVS Caremark.

Reconstructed IPD meta-analysis showed chemoimmunotherapy improved OS and PFS versus PD-(L)1 monotherapy within PD-L1–high disease, with consistent findings across multiple analytic approaches and ...